APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bone & Joint Health Ingredients

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bone & Joint Health Ingredients Market Outlook and Growth Opportunities 2026

21 December 2025200 pages

Choose your research edition.

Industry ResearchBone & Joint Health Ingredients Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Bone & Joint Health Ingredients Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Bone & Joint Health Ingredients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bone & Joint Health Ingredients Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Bone & Joint Health Ingredients Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Bone & Joint Health Ingredients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bone & Joint Health Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bone & Joint Health Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bone & Joint Health Ingredients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bone & Joint Health Ingredients market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bone & Joint Health Ingredients market include Shanxi Zhendong Pharmaceutical, By-Health, High Change, Harbin Pharmaceutical Group, GSK-Pfizer, Bayer, Swisse, Solgar and Schiff, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Bone & Joint Health Ingredients market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bone & Joint Health Ingredients and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bone & Joint Health Ingredients revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bone & Joint Health Ingredients market.

Bone & Joint Health Ingredients Segment by Company

Shanxi Zhendong Pharmaceutical

By-Health

High Change

Harbin Pharmaceutical Group

GSK-Pfizer

Bayer

Swisse

Solgar

Schiff

Pure Encapsulations

NOW Foods

Nature's Bounty

Nature Made

GNC Holdings

Bluebonnet Nutrition

Blackmores

BioTrust Nutrition

Bio Island

Amway (Nutrilite)

A&Z Pharmaceutical

Bone & Joint Health Ingredients Segment by Type

Omega-3 (Fish Oil)

Magnesium

Collagen

Turmeric

Calcium and Vitamin D3

Glucosamine and Chondroitin

Others

Bone & Joint Health Ingredients Segment by Application

Below 12 Years Old

Above 60 Years Old

50-60 Years Old

19-49 Years Old

12-18 Years Old

Bone & Joint Health Ingredients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bone & Joint Health Ingredients status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Bone & Joint Health Ingredients key companies, revenue, market share, and recent developments.

3. To split the Bone & Joint Health Ingredients breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Bone & Joint Health Ingredients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bone & Joint Health Ingredients significant trends, drivers, influence factors in global and regions.

6. To analyze Bone & Joint Health Ingredients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bone & Joint Health Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bone & Joint Health Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bone & Joint Health Ingredients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bone & Joint Health Ingredients industry.

Chapter 3: Detailed analysis of Bone & Joint Health Ingredients company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Bone & Joint Health Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Bone & Joint Health Ingredients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bone & Joint Health Ingredients Industry Trends Table 2. Bone & Joint Health Ingredients Industry Drivers Table 3. Bone & Joint Health Ingredients Industry Opportunities and Challenges Table 4. Bone & Joint Health Ingredients Industry Restraints Table 5. Global Bone & Joint Health Ingredients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bone & Joint Health Ingredients Revenue Share by Company (2021-2026) Table 7. Global Bone & Joint Health Ingredients Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Bone & Joint Health Ingredients Key Company Manufacturing Base & Headquarters Table 9. Global Bone & Joint Health Ingredients Company, Product Type & Application Table 10. Global Bone & Joint Health Ingredients Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Bone & Joint Health Ingredients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Omega-3 (Fish Oil) Table 15. Significant Companies of Magnesium Table 16. Significant Companies of Collagen Table 17. Significant Companies of Turmeric Table 18. Significant Companies of Calcium and Vitamin D3 Table 19. Significant Companies of Glucosamine and Chondroitin Table 20. Significant Companies of Others Table 21. Global Bone & Joint Health Ingredients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global Bone & Joint Health Ingredients Sales Value by Type (2021-2026) & (US$ Million) Table 23. Global Bone & Joint Health Ingredients Sales Value by Type (2027-2032) & (US$ Million) Table 24. Global Bone & Joint Health Ingredients Sales Value Share by Type (2021-2026) Table 25. Global Bone & Joint Health Ingredients Sales Value Share by Type (2027-2032) Table 26. Significant Companies of Below 12 Years Old Table 27. Significant Companies of Above 60 Years Old Table 28. Significant Companies of 50-60 Years Old Table 29. Significant Companies of 19-49 Years Old Table 30. Significant Companies of 12-18 Years Old Table 31. Global Bone & Joint Health Ingredients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Bone & Joint Health Ingredients Sales Value by Application (2021-2026) & (US$ Million) Table 33. Global Bone & Joint Health Ingredients Sales Value by Application (2027-2032) & (US$ Million) Table 34. Global Bone & Joint Health Ingredients Sales Value Share by Application (2021-2026) Table 35. Global Bone & Joint Health Ingredients Sales Value Share by Application (2027-2032) Table 36. Global Bone & Joint Health Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Bone & Joint Health Ingredients Sales Value by Region (2021-2026) & (US$ Million) Table 38. Global Bone & Joint Health Ingredients Sales Value Share by Region (2021-2026) Table 39. Global Bone & Joint Health Ingredients Sales Value by Region (2027-2032) & (US$ Million) Table 40. Global Bone & Joint Health Ingredients Sales Value Share by Region (2027-2032) Table 41. Global Bone & Joint Health Ingredients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Bone & Joint Health Ingredients Sales Value by Country (2021-2026) & (US$ Million) Table 43. Global Bone & Joint Health Ingredients Sales Value Market Share by Country (2021-2026) Table 44. Global Bone & Joint Health Ingredients Sales Value by Country (2027-2032) & (US$ Million) Table 45. Global Bone & Joint Health Ingredients Sales Value Market Share by Country (2027-2032) Table 46. Shanxi Zhendong Pharmaceutical Company Information Table 47. Shanxi Zhendong Pharmaceutical Business Overview Table 48. Shanxi Zhendong Pharmaceutical Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Shanxi Zhendong Pharmaceutical Bone & Joint Health Ingredients Product Portfolio Table 50. Shanxi Zhendong Pharmaceutical Recent Development Table 51. By-Health Company Information Table 52. By-Health Business Overview Table 53. By-Health Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. By-Health Bone & Joint Health Ingredients Product Portfolio Table 55. By-Health Recent Development Table 56. High Change Company Information Table 57. High Change Business Overview Table 58. High Change Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. High Change Bone & Joint Health Ingredients Product Portfolio Table 60. High Change Recent Development Table 61. Harbin Pharmaceutical Group Company Information Table 62. Harbin Pharmaceutical Group Business Overview Table 63. Harbin Pharmaceutical Group Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Harbin Pharmaceutical Group Bone & Joint Health Ingredients Product Portfolio Table 65. Harbin Pharmaceutical Group Recent Development Table 66. GSK-Pfizer Company Information Table 67. GSK-Pfizer Business Overview Table 68. GSK-Pfizer Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GSK-Pfizer Bone & Joint Health Ingredients Product Portfolio Table 70. GSK-Pfizer Recent Development Table 71. Bayer Company Information Table 72. Bayer Business Overview Table 73. Bayer Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Bayer Bone & Joint Health Ingredients Product Portfolio Table 75. Bayer Recent Development Table 76. Swisse Company Information Table 77. Swisse Business Overview Table 78. Swisse Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Swisse Bone & Joint Health Ingredients Product Portfolio Table 80. Swisse Recent Development Table 81. Solgar Company Information Table 82. Solgar Business Overview Table 83. Solgar Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Solgar Bone & Joint Health Ingredients Product Portfolio Table 85. Solgar Recent Development Table 86. Schiff Company Information Table 87. Schiff Business Overview Table 88. Schiff Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Schiff Bone & Joint Health Ingredients Product Portfolio Table 90. Schiff Recent Development Table 91. Pure Encapsulations Company Information Table 92. Pure Encapsulations Business Overview Table 93. Pure Encapsulations Bone & Joint Health Ingredients Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Pure Encapsulations Bone & Joint Health Ingredients Product Portfolio Table 95. Pure Encapsulations Recent Development Table 96. NOW Foods Company Information Table 97. NOW Foods Business Overview Table 98. NOW Foods Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. NOW Foods Bone & Joint Health Ingredients Product Portfolio Table 100. NOW Foods Recent Development Table 101. Nature's Bounty Company Information Table 102. Nature's Bounty Business Overview Table 103. Nature's Bounty Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Nature's Bounty Bone & Joint Health Ingredients Product Portfolio Table 105. Nature's Bounty Recent Development Table 106. Nature Made Company Information Table 107. Nature Made Business Overview Table 108. Nature Made Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Nature Made Bone & Joint Health Ingredients Product Portfolio Table 110. Nature Made Recent Development Table 111. GNC Holdings Company Information Table 112. GNC Holdings Business Overview Table 113. GNC Holdings Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. GNC Holdings Bone & Joint Health Ingredients Product Portfolio Table 115. GNC Holdings Recent Development Table 116. Bluebonnet Nutrition Company Information Table 117. Bluebonnet Nutrition Business Overview Table 118. Bluebonnet Nutrition Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Bluebonnet Nutrition Bone & Joint Health Ingredients Product Portfolio Table 120. Bluebonnet Nutrition Recent Development Table 121. Blackmores Company Information Table 122. Blackmores Business Overview Table 123. Blackmores Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Blackmores Bone & Joint Health Ingredients Product Portfolio Table 125. Blackmores Recent Development Table 126. BioTrust Nutrition Company Information Table 127. BioTrust Nutrition Business Overview Table 128. BioTrust Nutrition Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. BioTrust Nutrition Bone & Joint Health Ingredients Product Portfolio Table 130. BioTrust Nutrition Recent Development Table 131. Bio Island Company Information Table 132. Bio Island Business Overview Table 133. Bio Island Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Bio Island Bone & Joint Health Ingredients Product Portfolio Table 135. Bio Island Recent Development Table 136. Amway (Nutrilite) Company Information Table 137. Amway (Nutrilite) Business Overview Table 138. Amway (Nutrilite) Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Amway (Nutrilite) Bone & Joint Health Ingredients Product Portfolio Table 140. Amway (Nutrilite) Recent Development Table 141. A&Z Pharmaceutical Company Information Table 142. A&Z Pharmaceutical Business Overview Table 143. A&Z Pharmaceutical Bone & Joint Health Ingredients Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. A&Z Pharmaceutical Bone & Joint Health Ingredients Product Portfolio Table 145. A&Z Pharmaceutical Recent Development Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Bone & Joint Health Ingredients Product Image Figure 2. Global Bone & Joint Health Ingredients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bone & Joint Health Ingredients Market Size (2021-2032) & (US$ Million) Figure 4. Global Bone & Joint Health Ingredients Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Omega-3 (Fish Oil) Image Figure 8. Magnesium Image Figure 9. Collagen Image Figure 10. Turmeric Image Figure 11. Calcium and Vitamin D3 Image Figure 12. Glucosamine and Chondroitin Image Figure 13. Others Image Figure 14. Global Bone & Joint Health Ingredients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Bone & Joint Health Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Bone & Joint Health Ingredients Sales Value Share by Type (2021-2032) Figure 17. Below 12 Years Old Image Figure 18. Above 60 Years Old Image Figure 19. 50-60 Years Old Image Figure 20. 19-49 Years Old Image Figure 21. 12-18 Years Old Image Figure 22. Global Bone & Joint Health Ingredients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Bone & Joint Health Ingredients Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Bone & Joint Health Ingredients Sales Value Share by Application (2021-2032) Figure 25. Global Bone & Joint Health Ingredients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global Bone & Joint Health Ingredients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America Bone & Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 28. North America Bone & Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Europe Bone & Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 30. Europe Bone & Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Asia-Pacific Bone & Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Bone & Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 33. South America Bone & Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 34. South America Bone & Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Middle East & Africa Bone & Joint Health Ingredients Sales Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Bone & Joint Health Ingredients Sales Value Share by Country (%), 2025 VS 2032 Figure 37. USA Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. USA Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. USA Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Canada Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Canada Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Canada Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Mexico Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Mexico Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Mexico Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Germany Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Germany Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Germany Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. France Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. France Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. France Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. U.K. Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. U.K. Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. U.K. Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Italy Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Italy Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Italy Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Spain Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Spain Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Spain Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Russia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Russia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Russia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Netherlands Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Netherlands Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Netherlands Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Nordic Countries Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Nordic Countries Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Nordic Countries Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. China Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. China Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. China Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Japan Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Japan Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Japan Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. South Korea Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. South Korea Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. South Korea Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. India Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. India Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. India Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Australia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Australia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Australia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Southeast Asia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Southeast Asia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Southeast Asia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Brazil Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Brazil Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Brazil Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Argentina Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Argentina Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Argentina Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Chile Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Chile Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Chile Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Colombia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Colombia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Colombia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Peru Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Peru Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Peru Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Saudi Arabia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Israel Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Israel Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Israel Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. UAE Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. UAE Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. UAE Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Turkey Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Turkey Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Turkey Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Iran Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Iran Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Iran Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Egypt Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Egypt Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Egypt Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Years Considered Figure 122. Research Process Figure 123. Key Executives Interviewed

Scope & coverage.

Types
  • Omega-3 (Fish Oil)
  • Magnesium
  • Collagen
  • Turmeric
  • Calcium and Vitamin D3
  • Glucosamine and Chondroitin
  • Others
Applications
  • Below 12 Years Old
  • Above 60 Years Old
  • 50-60 Years Old
  • 19-49 Years Old
  • 12-18 Years Old
Companies covered
  • Shanxi Zhendong Pharmaceutical
  • By-Health
  • High Change
  • Harbin Pharmaceutical Group
  • GSK-Pfizer
  • Bayer
  • Swisse
  • Solgar
  • Schiff
  • Pure Encapsulations
  • NOW Foods
  • Nature's Bounty
  • Nature Made
  • GNC Holdings
  • Bluebonnet Nutrition
  • Blackmores
  • BioTrust Nutrition
  • Bio Island
  • Amway (Nutrilite)
  • A&Z Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bone & Joint Health Ingredients Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bone & Joint Health Ingredients Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Bone & Joint Health Ingredients Market Dynamics
  1. 2.1 Bone & Joint Health Ingredients Industry Trends
  2. 2.2 Bone & Joint Health Ingredients Industry Drivers
  3. 2.3 Bone & Joint Health Ingredients Industry Opportunities and Challenges
  4. 2.4 Bone & Joint Health Ingredients Industry Restraints
3 Bone & Joint Health Ingredients Market by Company
  1. 3.1 Global Bone & Joint Health Ingredients Company Revenue Ranking in 2025
  2. 3.2 Global Bone & Joint Health Ingredients Revenue by Company (2021-2026)
  3. 3.3 Global Bone & Joint Health Ingredients Company Ranking (2024-2026)
  4. 3.4 Global Bone & Joint Health Ingredients Company Manufacturing Base and Headquarters
  5. 3.5 Global Bone & Joint Health Ingredients Company Product Type and Application
  6. 3.6 Global Bone & Joint Health Ingredients Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Bone & Joint Health Ingredients Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Bone & Joint Health Ingredients Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Bone & Joint Health Ingredients Market by Type
  1. 4.1 Bone & Joint Health Ingredients Type Introduction
  2. 4.1.1 Omega-3 (Fish Oil)
  3. 4.1.2 Magnesium
  4. 4.1.3 Collagen
  5. 4.1.4 Turmeric
  6. 4.1.5 Calcium and Vitamin D3
  7. 4.1.6 Glucosamine and Chondroitin
  8. 4.1.7 Others
  9. 4.2 Global Bone & Joint Health Ingredients Sales Value by Type
  10. 4.2.1 Global Bone & Joint Health Ingredients Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Bone & Joint Health Ingredients Sales Value by Type (2021-2032)
  12. 4.2.3 Global Bone & Joint Health Ingredients Sales Value Share by Type (2021-2032)
5 Bone & Joint Health Ingredients Market by Application
  1. 5.1 Bone & Joint Health Ingredients Application Introduction
  2. 5.1.1 Below 12 Years Old
  3. 5.1.2 Above 60 Years Old
  4. 5.1.3 50-60 Years Old
  5. 5.1.4 19-49 Years Old
  6. 5.1.5 12-18 Years Old
  7. 5.2 Global Bone & Joint Health Ingredients Sales Value by Application
  8. 5.2.1 Global Bone & Joint Health Ingredients Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Bone & Joint Health Ingredients Sales Value by Application (2021-2032)
  10. 5.2.3 Global Bone & Joint Health Ingredients Sales Value Share by Application (2021-2032)
6 Bone & Joint Health Ingredients Regional Value Analysis
  1. 6.1 Global Bone & Joint Health Ingredients Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bone & Joint Health Ingredients Sales Value by Region (2021-2032)
  3. 6.2.1 Global Bone & Joint Health Ingredients Sales Value by Region: 2021-2026
  4. 6.2.2 Global Bone & Joint Health Ingredients Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bone & Joint Health Ingredients Sales Value (2021-2032)
  7. 6.3.2 North America Bone & Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Bone & Joint Health Ingredients Sales Value (2021-2032)
  10. 6.4.2 Europe Bone & Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Bone & Joint Health Ingredients Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Bone & Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Bone & Joint Health Ingredients Sales Value (2021-2032)
  16. 6.6.2 South America Bone & Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Bone & Joint Health Ingredients Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Bone & Joint Health Ingredients Sales Value Share by Country, 2025 VS 2032
7 Bone & Joint Health Ingredients Country-level Value Analysis
  1. 7.1 Global Bone & Joint Health Ingredients Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bone & Joint Health Ingredients Sales Value by Country (2021-2032)
  3. 7.2.1 Global Bone & Joint Health Ingredients Sales Value by Country (2021-2026)
  4. 7.2.2 Global Bone & Joint Health Ingredients Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Bone & Joint Health Ingredients Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Bone & Joint Health Ingredients Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Bone & Joint Health Ingredients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanxi Zhendong Pharmaceutical
  2. 8.1.1 Shanxi Zhendong Pharmaceutical Company Information
  3. 8.1.2 Shanxi Zhendong Pharmaceutical Business Overview
  4. 8.1.3 Shanxi Zhendong Pharmaceutical Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanxi Zhendong Pharmaceutical Bone & Joint Health Ingredients Product Portfolio
  6. 8.1.5 Shanxi Zhendong Pharmaceutical Recent Developments
  7. 8.2 By-Health
  8. 8.2.1 By-Health Company Information
  9. 8.2.2 By-Health Business Overview
  10. 8.2.3 By-Health Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  11. 8.2.4 By-Health Bone & Joint Health Ingredients Product Portfolio
  12. 8.2.5 By-Health Recent Developments
  13. 8.3 High Change
  14. 8.3.1 High Change Company Information
  15. 8.3.2 High Change Business Overview
  16. 8.3.3 High Change Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  17. 8.3.4 High Change Bone & Joint Health Ingredients Product Portfolio
  18. 8.3.5 High Change Recent Developments
  19. 8.4 Harbin Pharmaceutical Group
  20. 8.4.1 Harbin Pharmaceutical Group Company Information
  21. 8.4.2 Harbin Pharmaceutical Group Business Overview
  22. 8.4.3 Harbin Pharmaceutical Group Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Harbin Pharmaceutical Group Bone & Joint Health Ingredients Product Portfolio
  24. 8.4.5 Harbin Pharmaceutical Group Recent Developments
  25. 8.5 GSK-Pfizer
  26. 8.5.1 GSK-Pfizer Company Information
  27. 8.5.2 GSK-Pfizer Business Overview
  28. 8.5.3 GSK-Pfizer Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GSK-Pfizer Bone & Joint Health Ingredients Product Portfolio
  30. 8.5.5 GSK-Pfizer Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Bone & Joint Health Ingredients Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 Swisse
  38. 8.7.1 Swisse Company Information
  39. 8.7.2 Swisse Business Overview
  40. 8.7.3 Swisse Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Swisse Bone & Joint Health Ingredients Product Portfolio
  42. 8.7.5 Swisse Recent Developments
  43. 8.8 Solgar
  44. 8.8.1 Solgar Company Information
  45. 8.8.2 Solgar Business Overview
  46. 8.8.3 Solgar Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Solgar Bone & Joint Health Ingredients Product Portfolio
  48. 8.8.5 Solgar Recent Developments
  49. 8.9 Schiff
  50. 8.9.1 Schiff Company Information
  51. 8.9.2 Schiff Business Overview
  52. 8.9.3 Schiff Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Schiff Bone & Joint Health Ingredients Product Portfolio
  54. 8.9.5 Schiff Recent Developments
  55. 8.10 Pure Encapsulations
  56. 8.10.1 Pure Encapsulations Company Information
  57. 8.10.2 Pure Encapsulations Business Overview
  58. 8.10.3 Pure Encapsulations Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pure Encapsulations Bone & Joint Health Ingredients Product Portfolio
  60. 8.10.5 Pure Encapsulations Recent Developments
  61. 8.11 NOW Foods
  62. 8.11.1 NOW Foods Company Information
  63. 8.11.2 NOW Foods Business Overview
  64. 8.11.3 NOW Foods Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NOW Foods Bone & Joint Health Ingredients Product Portfolio
  66. 8.11.5 NOW Foods Recent Developments
  67. 8.12 Nature's Bounty
  68. 8.12.1 Nature's Bounty Company Information
  69. 8.12.2 Nature's Bounty Business Overview
  70. 8.12.3 Nature's Bounty Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nature's Bounty Bone & Joint Health Ingredients Product Portfolio
  72. 8.12.5 Nature's Bounty Recent Developments
  73. 8.13 Nature Made
  74. 8.13.1 Nature Made Company Information
  75. 8.13.2 Nature Made Business Overview
  76. 8.13.3 Nature Made Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Nature Made Bone & Joint Health Ingredients Product Portfolio
  78. 8.13.5 Nature Made Recent Developments
  79. 8.14 GNC Holdings
  80. 8.14.1 GNC Holdings Company Information
  81. 8.14.2 GNC Holdings Business Overview
  82. 8.14.3 GNC Holdings Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  83. 8.14.4 GNC Holdings Bone & Joint Health Ingredients Product Portfolio
  84. 8.14.5 GNC Holdings Recent Developments
  85. 8.15 Bluebonnet Nutrition
  86. 8.15.1 Bluebonnet Nutrition Company Information
  87. 8.15.2 Bluebonnet Nutrition Business Overview
  88. 8.15.3 Bluebonnet Nutrition Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bluebonnet Nutrition Bone & Joint Health Ingredients Product Portfolio
  90. 8.15.5 Bluebonnet Nutrition Recent Developments
  91. 8.16 Blackmores
  92. 8.16.1 Blackmores Company Information
  93. 8.16.2 Blackmores Business Overview
  94. 8.16.3 Blackmores Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Blackmores Bone & Joint Health Ingredients Product Portfolio
  96. 8.16.5 Blackmores Recent Developments
  97. 8.17 BioTrust Nutrition
  98. 8.17.1 BioTrust Nutrition Company Information
  99. 8.17.2 BioTrust Nutrition Business Overview
  100. 8.17.3 BioTrust Nutrition Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BioTrust Nutrition Bone & Joint Health Ingredients Product Portfolio
  102. 8.17.5 BioTrust Nutrition Recent Developments
  103. 8.18 Bio Island
  104. 8.18.1 Bio Island Company Information
  105. 8.18.2 Bio Island Business Overview
  106. 8.18.3 Bio Island Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bio Island Bone & Joint Health Ingredients Product Portfolio
  108. 8.18.5 Bio Island Recent Developments
  109. 8.19 Amway (Nutrilite)
  110. 8.19.1 Amway (Nutrilite) Company Information
  111. 8.19.2 Amway (Nutrilite) Business Overview
  112. 8.19.3 Amway (Nutrilite) Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Amway (Nutrilite) Bone & Joint Health Ingredients Product Portfolio
  114. 8.19.5 Amway (Nutrilite) Recent Developments
  115. 8.20 A&Z Pharmaceutical
  116. 8.20.1 A&Z Pharmaceutical Company Information
  117. 8.20.2 A&Z Pharmaceutical Business Overview
  118. 8.20.3 A&Z Pharmaceutical Bone & Joint Health Ingredients Revenue and Gross Margin (2021-2026)
  119. 8.20.4 A&Z Pharmaceutical Bone & Joint Health Ingredients Product Portfolio
  120. 8.20.5 A&Z Pharmaceutical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst